| IBCASERTIB | Small molecule | triple-negative breast cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Recruiting | ClinicalTrials |
| IBCASERTIB | Small molecule | non-Hodgkins lymphoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| IBCASERTIB | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 3.0 | Recruiting | ClinicalTrials |
| ENMD-2076 | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | lymphoid neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | myelodysplastic syndrome | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| MK-6592 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| SNS-314 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| BARASERTIB | Small molecule | lymphoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| BARASERTIB | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Terminated | ClinicalTrials |
| TAK-901 | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TTP-607 | Small molecule | cancer | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| ENMD-2076 | Small molecule | breast cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| IBCASERTIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| KW-2449 | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Terminated | ClinicalTrials |
| IBCASERTIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| BARASERTIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| TTP-607 | Small molecule | lymphoma | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| CYC-116 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| IBCASERTIB | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Recruiting | ClinicalTrials |
| ENMD-2076 | Small molecule | ovarian cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | chronic myelogenous leukemia | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| AT-9283 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Terminated | ClinicalTrials |
| BI-811283 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| DANUSERTIB | Small molecule | leukemia | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Unknown status | ClinicalTrials |
| IBCASERTIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 3.0 | Recruiting | ClinicalTrials |
| TOZASERTIB | Small molecule | cancer | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| ILORASERTIB | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | multiple myeloma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| DANUSERTIB | Small molecule | prostate cancer | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Completed | ClinicalTrials |
| BARASERTIB | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| ILORASERTIB | Small molecule | cancer | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| ENMD-2076 | Small molecule | clear cell adenocarcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | myelodysplastic syndrome | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| BARASERTIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | chronic myelogenous leukemia | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| AT-9283 | Small molecule | non-Hodgkins lymphoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | acute lymphoblastic leukemia | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| BARASERTIB | Small molecule | myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | Fallopian Tube Carcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| DANUSERTIB | Small molecule | multiple myeloma | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Terminated | ClinicalTrials |
| IBCASERTIB | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | lymphoid leukemia | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | peritoneum cancer | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| CENISERTIB | Small molecule | lymphoid neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Terminated | ClinicalTrials |
| TAK-901 | Small molecule | myelofibrosis | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| IBCASERTIB | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AMG-900 | Small molecule | myeloid leukemia | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | chronic lymphocytic leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| AMG-900 | Small molecule | cancer | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| CENISERTIB | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| ENMD-2076 | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | primary myelofibrosis | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| PF-03814735 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| BI-811283 | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| TOZASERTIB | Small molecule | leukemia | Serine/threonine-protein kinase Aurora inhibitor | 2.0 | Terminated | ClinicalTrials |
| AT-9283 | Small molecule | multiple myeloma | Serine/threonine-protein kinase Aurora-B inhibitor | 2.0 | Completed | ClinicalTrials |
| GSK-1070916 | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| IBCASERTIB | Small molecule | non-Hodgkins lymphoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Terminated | ClinicalTrials |
| IBCASERTIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | lymphoma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | multiple myeloma | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| TAK-901 | Small molecule | Waldenstrom macroglobulinemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |
| ILORASERTIB | Small molecule | neoplasm | Serine/threonine-protein kinase Aurora inhibitor | 1.0 | Completed | ClinicalTrials |
| AT-9283 | Small molecule | leukemia | Serine/threonine-protein kinase Aurora-B inhibitor | 1.0 | Completed | ClinicalTrials |